Bank of America
ONCY

Bank of America’s Oncolytics Biotech ONCY Stock Holding History

Bank of America’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$874 – 6541
2025
Q4 		$874 Hold
1,000
– – ﹤0.01% 6483
2025
Q3 		$1.4K Buy
+1,000
New +$1.12K ﹤0.01% 7447
2024
Q4 		– Sell
-1,800
Closed -$1.57K – 8346
2024
Q3 		$1.57K Buy
+1,800
New +$1.77K ﹤0.01% 7165
2024
Q1 		– Sell
-6,101
Closed -$8.24K – 8059
2023
Q4 		$8.24K Buy
6,101
+1,374
+29% +$2.15K ﹤0.01% 6929
2023
Q3 		$10.3K Buy
4,727
+85
+2% +$208 ﹤0.01% 6857
2023
Q2 		$12.1K Buy
4,642
+635
+16% +$1.05K ﹤0.01% 6818
2023
Q1 		$4.81K Sell
4,007
-1,988
-33% -$3.12K ﹤0.01% 7079
2022
Q4 		$9.77K Buy
5,995
+2,394
+66% +$3.63K ﹤0.01% 6925
2022
Q3 		$4K Buy
3,601
+357
+11% +$437 ﹤0.01% 7441
2022
Q2 		$3K Buy
3,244
+191
+6% +$232 ﹤0.01% 7716
2022
Q1 		$5K Sell
3,053
-12,000
-80% -$20.1K ﹤0.01% 7897
2021
Q4 		$21K Sell
15,053
-12,160
-45% -$22.5K ﹤0.01% 7506
2021
Q3 		$56K Sell
27,213
-22,199
-45% -$50.3K ﹤0.01% 6994
2021
Q2 		$137K Sell
49,412
-12,940
-21% -$39.6K ﹤0.01% 6326
2021
Q1 		$237K Buy
62,352
+41,300
+196% +$123K ﹤0.01% 5911
2020
Q4 		$50K Buy
21,052
+10,462
+99% +$25.1K ﹤0.01% 6329
2020
Q3 		$18K Buy
10,590
+8,796
+490% +$16.1K ﹤0.01% 6317
2020
Q2 		$4K Buy
1,794
+927
+107% +$1.75K ﹤0.01% 6587
2020
Q1 		$1K Sell
867
-394
-31% -$983 ﹤0.01% 6725
2019
Q4 		$6K Buy
1,261
+894
+244% +$1.01K ﹤0.01% 6736
2019
Q3 		$0 Hold
367
– – ﹤0.01% 7426
2019
Q2 		$1K Sell
367
-100
-21% -$181 ﹤0.01% 7046
2019
Q1 		$1K Sell
467
-215
-32% -$436 ﹤0.01% 6984
2018
Q4 		$1K Buy
682
+105
+18% +$284 ﹤0.01% 6984
2018
Q3 		$2K Sell
577
-1,100
-66% -$5.11K ﹤0.01% 7027
2018
Q2 		$9K Buy
+1,677
New +$10.3K ﹤0.01% 6685

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America's ONCY Position: Q1 2026 in Review

Bank of America sold out of Oncolytics Biotech (ONCY) in Q1 2026, closing a stake of 1,000 shares — an estimated $874 sold.

Bank of America first reported a position in ONCY in Q2 2018 and held it in 26 quarters. The position peaked at $237K in Q1 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Bank of America reported no remaining Oncolytics Biotech position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,000 Oncolytics Biotech shares in Q1 2026, an estimated $874.
  • Bank of America first reported a position in Oncolytics Biotech in Q2 2018 and held it in 26 quarters.
  • Bank of America's Oncolytics Biotech position peaked at $237K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.